Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Internal Audit Planning and Execution – V 2.0

Posted on By

API Manufacturing: SOP for Internal Audit Planning and Execution – V 2.0

Standard Operating Procedure for Internal Audit Planning and Execution in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/167/2025
Supersedes SOP/API/167/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a documented system for planning, conducting, documenting, and following up on internal audits within API manufacturing units in order to assess compliance with Good Manufacturing Practices (GMP), internal policies, and regulatory standards.

2. Scope

This SOP applies to all internal audits conducted by the Quality Assurance (QA) department at the API manufacturing facility, covering manufacturing, warehousing, quality

control, engineering, utilities, and support functions.

3. Responsibilities

  • QA Department: Prepare audit schedules, assign auditors, conduct audits, document findings, and ensure CAPA closure.
  • Auditors: Conduct unbiased evaluations and document observations clearly.
  • Auditees (Departments): Facilitate audit process and provide required documents and responses to observations.
  • QA Head: Review audit reports and monitor CAPA effectiveness.

4. Accountability

The QA Head is accountable for the successful execution of internal audits and ensuring closure of all observations through timely and effective corrective and preventive actions.

See also  API Manufacturing: SOP for Handling of Incidental Lab Spills - V 2.0

5. Procedure

5.1 Internal Audit Planning

  1. QA shall prepare an Annual Internal Audit Schedule (Annexure-1) at the beginning of each calendar year.
  2. Frequency of audits:
    • GMP areas – At least once every 6 months
    • Support departments – Once annually
    • Trigger-based audits – As needed following complaints, deviations, or inspections

5.2 Auditor Selection and Training

  1. Internal auditors shall be qualified personnel trained in auditing techniques and GMP requirements.
  2. Auditors must be independent of the area being audited to ensure objectivity.
  3. Training records of auditors shall be maintained by QA.

5.3 Audit Preparation

  1. QA shall issue an Internal Audit Intimation (Annexure-2) to the auditee department at least 3 days in advance.
  2. Audit Checklist (Annexure-3) shall be prepared based on:
    • Previous audit observations
    • Applicable SOPs, guidelines, and regulatory requirements
    • Any specific focus areas

5.4 Conducting the Audit

  1. The audit shall include:
    • Opening meeting with the auditee
    • Facility walkthrough and interviews
    • Review of documents, records, logs, and equipment
  2. All observations shall be documented clearly as:
    • Critical: Direct impact on product quality/safety or regulatory non-compliance
    • Major: Potential to affect product quality or documentation integrity
    • Minor: Improvement areas not immediately affecting quality
  3. Close the audit with an exit meeting and initial discussion on observations.

5.5 Audit Report Preparation

  1. Complete the Internal Audit Report (Annexure-4) within 5 working days of audit completion.
  2. Include:
    • Audit date and scope
    • Auditors and auditees involved
    • Observations categorized by severity
    • Photos or evidence if applicable
  3. Distribute the report to department heads and management.
See also  API Manufacturing: SOP for Screening of Final API Powder - V 2.0

5.6 Corrective and Preventive Action (CAPA)

  1. Auditee departments shall submit CAPA responses within 10 working days using the CAPA Response Form (Annexure-5).
  2. QA shall review the adequacy of CAPA and request clarification if required.
  3. QA shall verify effectiveness of actions implemented and document closure in the Audit CAPA Tracker (Annexure-6).

5.7 Re-Audit and Follow-up

  1. QA may schedule a re-audit in case of critical observations or ineffective CAPA implementation.
  2. Follow-up audits shall be documented using a Follow-Up Audit Form (Annexure-7).

5.8 Audit Summary and Trending

  1. QA shall maintain a Master Audit Summary (Annexure-8) capturing:
    • Total audits conducted
    • Observation types and recurring issues
    • CAPA timelines and closures
  2. Summarized trends and performance metrics shall be discussed in quarterly Quality Management Review (QMR) meetings.

6. Abbreviations

  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practices
  • QMR: Quality Management Review

7. Documents

  1. Annual Audit Schedule (Annexure-1)
  2. Audit Intimation Form (Annexure-2)
  3. Audit Checklist (Annexure-3)
  4. Internal Audit Report (Annexure-4)
  5. CAPA Response Form (Annexure-5)
  6. Audit CAPA Tracker (Annexure-6)
  7. Follow-Up Audit Form (Annexure-7)
  8. Master Audit Summary Sheet (Annexure-8)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211.180 – Recordkeeping Requirements
  • WHO GMP – Annex 3: Quality Management System
See also  API Manufacturing: SOP for Cleaning of Milling Equipment - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Annual Internal Audit Schedule

Department Audit Frequency Planned Date Status
Production 6 Monthly 01/03/2025 Completed

Annexure-2: Internal Audit Intimation Form

Date Department Audit Scope Auditor
28/02/2025 QC Data Integrity and Instrument Logs Rajesh Kumar

Annexure-3: Audit Checklist

Audit Area Requirement Compliant (Y/N) Remarks
Documentation SOPs in place and current Y

Annexure-4: Internal Audit Report

Observation No. Category Description Department
01 Major Incomplete logbook entries Production

Annexure-5: CAPA Response Form

Observation No. Root Cause CAPA Proposed Target Date
01 Staff unaware of SOP changes Retraining 10/03/2025

Annexure-6: Audit CAPA Tracker

CAPA ID Status Verified By Closure Date
CAPA/2025/008 Closed QA 15/03/2025

Annexure-7: Follow-Up Audit Form

Original Audit Date Re-Audit Date Findings Closed Remarks
01/03/2025 10/03/2025 Yes Effective CAPA

Annexure-8: Master Audit Summary Sheet

Audit No. Area Audited Observations CAPA Status
INT/2025/03 Warehouse 2 Minor Closed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release Implementation QA Head
14/04/2025 2.0 Updated audit classification and annexures Compliance Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Development of Drug Release Profile – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Filtration Process in Sterile Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version